Primary pulmonary hypertension: Pathologist as patient

Journal of the Royal College of Physicians of London

Volumn 32, Issue 3, 1998, Pages 225-230

  Polak, Julia A ^c   Oakley, Celia M ^c   Yacoub, Magdi ^a   Mikhail, Ghada ^a   Taylor Robinson, Simon D ^b  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c Hammersmith Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; FENFLURAMINE; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; BIOPSY; CASE REPORT; CHEMICALLY INDUCED DISORDER; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HUMAN; LUNG; LUNG FUNCTION TEST; PATHOLOGY; PULMONARY HYPERTENSION; TIME;

ADULT; APPETITE DEPRESSANTS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FENFLURAMINE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; IMMUNOSUPPRESSIVE AGENTS; LUNG; RESPIRATORY FUNCTION TESTS; TACROLIMUS; TIME FACTORS;

EID: 0032067467     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J 1986;55: 449-58.
2. Zaia JA, Gallez-Hawkins G, Churchill MA, Morton-Blackshere A, et al. Comparative analysis of human cytomegalovirus α - sequence in multiple clinical isolates by using polymerase chain reaction and restriction fragment length polymorphism assays. J Clin Microbiol 1990;28:2602-7
3. Smith JD, Danskine AJ, Laylor RM, Rose ML, Yacoub MH. The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. Transplant Immunology 1993;1:60-5.
4. Habib S, Hoskin P, Rose M, Khaghani A, et al. A comparison of tacrolimus and total lymphoid irradiation in the management of post transplant bronchiolitis obliterans syndrome (abstract). J Heart and Lung Transplant (in press).
5. Hatano S, Strarrer T. Primary pulmonary hypertension. Report of Committee. Geneva: World Health Organisation, 1995.
6. Mason NA, Springall DR, Burke M, Pollock J, et al. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. J Pathol (in press).
7. Barnes PJ. Nitric oxide and airway disease. Ann Med 1995;27: 389-93.
8. Channick RN, Williams PJ, Newhart JM, Johnson FW, McIntyre D. Chronic inhaled nitric oxide in the outpatient treatment of primary pulmonary hypertension. Am J Respir Crit Care Med 1996;153:A86.
9. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995;333:214-21.
10. Mikhail G, Al-Kattan K, Banner N, Mitchell A, et al. Long term results of heart lung transplantation for pulmonary hypertension. Transplantation Proceedings 1997;29:633.
11. Barst RJ, Rubin LJ, Long WA, McGoon MD, et al. A comparison of continuous intavenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996;334:296-301.
12. Lam K, Oldenburg N, Khan M, Mikhail G, et al. The significance of human cytomegalovirus early transcript as a marker of active infection in transplant recipients (abstract). Circulation 1996;94:478.
13. Oakley CM. Primary pulmonary hypertension. Case series from the United Kingdom. Chest 1994;105(Suppl):29-32.
14. Abenhaim L, Moride Y, Brenot F, Rich S, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med 1996;335:609-16.
15. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-9.
16. Bass O, Gurtner HP. Evolution of primary pulmonary hypertension following ingestion of aminorex fumarate (Menocil). Preliminary communication. Schweiz Med Wochenschr 1973;103:1794.
17. Gurtner HP. Aminorex and pulmonary hypertension. Cor Vasa 1985;27:160-71.